The importance of immunocompetent cells in the course of bronchial obstruction syndrome

The use of immunomodulatory drug in a complex therapy of recurrent bronchial obstruction syndrome in children has been found to attain the best indexes of NK-cells number, T lymphocytes and B lymphocytes in the blood serum with markers CD3+, CD4+, CD19+, CD4+/CD8+ and reduction T-lymphocytes number with marker CD8+ in comparison with the control group. After the treatment using Azoximer bromide in children with bronchial asthma and recurrent bronchitis has been found to attain significant increase of the phagocytic activity of neutrophils.